The DOI matches its Crossref record; 328 of the 335 references it cites were found in a registry or an index.
Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update
Open accessAbstract
BACKGROUND: Cannabis use is common, especially among young people, and is associated with risks for various health harms. Some jurisdictions have recently moved to legalization/regulation pursuing public health goals. Evidence-based 'Lower Risk Cannabis Use Guidelines' (LRCUG) and recommendations were previously developed to reduce modifiable risk factors of cannabis-related adverse health outcomes; related evidence has evolved substantially since. We aimed to review new scientific evidence and to develop comprehensively up-to-date LRCUG, including their recommendations, on this evidence basis. METHODS: Targeted searches for literature (since 2016) on main risk factors for cannabis-related adverse health outcomes modifiable by the user-individual were conducted. Topical areas were informed by previous LRCUG content and expanded upon current evidence. Searches preferentially focused on systematic reviews, supplemented by key individual studies. The review results were evidence-graded, topically organized and narratively summarized; recommendations were developed through an iterative scientific expert consensus development process. RESULTS: A substantial body of modifiable risk factors for cannabis use-related health harms were identified with varying evidence quality. Twelve substantive recommendation clusters and three precautionary statements were developed. In general, current evidence suggests that individuals can substantially reduce their risk for adverse health outcomes if they delay the onset of cannabis use until after adolescence, avoid the use of high-potency (THC) cannabis products and high-frequency/-intensity of use, and refrain from smoking-routes for administration. While young people are particularly vulnerable to cannabis-related harms, other sub-groups (e.g., pregnant women, drivers, older adults, those with co-morbidities) are advised to exercise particular caution with use-related risks. Legal/regulated cannabis products should be used where possible. CONCLUSIONS: Cannabis use can result in adverse health outcomes, mostly among sub-groups with higher-risk use. Reducing the risk factors identified can help to reduce health harms from use. The LRCUG offer one targeted intervention component within a comprehensive public health approach for cannabis use. They require effective audience-tailoring and dissemination, regular updating as new evidence become available, and should be evaluated for their impact.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, recently updated ‘Lower-Risk Cannabis Use Guidelines’ were largely unable to list risk-thresholds for main adverse outcomes due to a lack of adequately quantified exposure data (Fischer et al., 2022).”
From Risk-thresholds for the association between frequency of cannabis use and the development of psychosis: a systematic review and meta-analysis (2023) · cites this paper as Fischer et al., 2022
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Does tailoring matter? Meta-analytic review of tailored print health behavior change interventions
Noar, S. M., Benac, C. N., & Harris, M. S. (2007) · Psychological Bulletin · doi:10.1037/0033-2909.133.4.673 · Cited by 2,136
Writing narrative style literature reviews
Ferrari, R. (2015) · Medical Writing · doi:10.1179/2047480615z.000000000329 · Cited by 1,907
Kushi, L. H., Byers, T., Doyle, C., Bandera, E. V., McCullough, M., Gansler, T., Andrews, K. S., Thun, M. J., & The American Cancer Society 2006 Nutrition and Physical Activity Guidelines Advisory Committee (2006) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.5.254 · Cited by 1,901
Degenhardt, L., Charlson, F., Ferrari, A., Santomauro, D., Erskine, H., Mantilla-Herrara, A., Whiteford, H., Leung, J., Naghavi, M., Griswold, M., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30337-7 · Cited by 1,572
American Cancer Society guidelines on nutrition and physical activity for cancer prevention
Kushi, L. H., Doyle, C., McCullough, M. L., Rock, C. L., Demark‐Wahnefried, W., Bandera, E. V., Gapstur, S. M., Patel, A. V., Andrews, K. S., & Gansler, T. S. (2012) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20140 · Cited by 1,399
Wood, A. M., Kaptoge, S., Butterworth, A. S., Willeit, P., Warnakula, S., Bolton, T., Paige, E., Paul, D. S., Sweeting, M., Burgess, S., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30134-x · Cited by 1,188
Gobbi, G., Atkin, T., Zytynski, T., Wang, S., Askari, S., Boruff, J., Ware, M., Marmorstein, N., Cipriani, A., Dendukuri, N., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.4500 · Cited by 914 · cited 2×
“[ Evidence Grade: Substantial to Limited ]”
BackgroundInfluentialDi Forti, M., Quattrone, D., Freeman, T. P., Tripoli, G., Gayer-Anderson, C., Quigley, H., Rodriguez, V., Jongsma, H. E., Ferraro, L., La Cascia, C., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30048-3 · Cited by 875
Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
Volkow, N. D., Swanson, J. M., Evins, A. E., DeLisi, L. E., Meier, M. H., Gonzalez, R., Bloomfield, M. A. P., Curran, H. V., & Baler, R. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.3278 · Cited by 867
A meta-analysis of computer-tailored interventions for health behavior change
Krebs, P., Prochaska, J. O., & Rossi, J. S. (2010) · Preventive Medicine · doi:10.1016/j.ypmed.2010.06.004 · Cited by 854
Cited by
Sorted by citations
Items 101–200 of 235
Roberts, S. C. M., Raifman, S., & Biggs, M. A. (2022) · Preventive Medicine · doi:10.1016/j.ypmed.2022.107297 · Cited by 3
A First-Tier Framework for Assessing Toxicological Risk from Vaporized Cannabis Concentrates
Vreeke, S., Faulkner, D. M., Strongin, R. M., & Rufer, E. S. (2022) · Toxics · doi:10.3390/toxics10120771 · Cited by 3
Coelho, S. G., & Wardell, J. D. (2023) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2023.104076 · Cited by 4
Haddad, R., Dagenais, C., Huỳnh, C., & Fallu, J. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-078427 · Cited by 3
O’Donnell, S., Scott-Storey, K. A., Malcolm, J., Vincent, C. D., & Wuest, J. (2024) · Research in Nursing & Health · doi:10.1002/nur.22389 · Cited by 3
Balneaves, L. G., Hammond, D. G., Turner, S., Nickel, N. C., Woodgate, R. L., & Watling, C. Z. (2024) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2024.2371028 · Cited by 3
Considering Long-Acting Synthetic Cannabidiol for Chronic Pain: A Narrative Review
Christo, P. J., Vortsman, E., Gharibo, C. G., LeQuang, J. A., & Pergolizzi, J. V. (2025) · Cureus · doi:10.7759/cureus.81577 · Cited by 3
Hultgren, B. A., Guttmannova, K., Lee, C. M., Acuna, D., Cooper, R. L., Kilmer, J. R., Cadigan, J. M., Calhoun, B. H., & Larimer, M. E. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275190 · Cited by 3
Brief Interventions for Cannabis Using Adolescents
Winters, K. C., Waldron, H. B., Hops, H., Ozechowski, T. J., & Montano, A. (2022) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2022.06.004 · Cited by 3
Lapham, G. T., Bobb, J. F., Luce, C., Oliver, M. M., Hamilton, L., Hyun, N., Hallgren, K. A., & Matson, T. E. (2024) · Journal of General Internal Medicine · doi:10.1007/s11606-024-09061-6 · Cited by 2
Cui, H., Chen, D., Cai, M., Cao, K., Gao, B., Zhu, H., Wang, X., & Wang, P. (2025) · Industrial Crops and Products · doi:10.1016/j.indcrop.2025.121316 · Cited by 2
Berny, L. M., Nichols, L. M., Schweer‐Collins, M. L., & Tanner‐Smith, E. E. (2025) · Prevention Science · doi:10.1007/s11121-025-01826-7 · Cited by 2
MacDonald‐Spracklin, R., DeWolf, D., & Thompson, K. (2025) · Substance Use & Misuse · doi:10.1080/10826084.2025.2538733 · Cited by 2
From farm to bedside: Potential of medical cannabis in global health
Tendwa, M. B., Appidi, T., Chitsunge, B., Moreau, M., Okole, B., Kalombo, L., Mallum, A. A., Ngoma, T. A., Weadock, D. P., Tanifum, E. A., et al. (2025) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2025.103205 · Cited by 2
Mizuno, S., Inoura, S., Matsumoto, T., Kitagaki, K., Koide, A., Takehara, K., & Shimane, T. (2025) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.70241 · Cited by 2
Watts, J. J., Navarri, X., & Conrod, P. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02249-2 · Cited by 5
Goulet-Stock, S., Hacksel, C., Scandiuzzi, B., Boyd, R., Pauly, B., & Stockwell, T. R. (2025) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2025.105083 · Cited by 2
The Exploration of Cannabis Beverage Substitution for Alcohol: A Novel Harm Reduction Strategy
Kruger, J. S., Felicione, N. J., & Kruger, D. J. (2026) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2026.2614506 · Cited by 2
Rychert, M., Gagnon, F. M., Wilkins, C., & Kilmer, B. (2026) · Contemporary Drug Problems · doi:10.1177/00914509261416113 · Cited by 2
Antwi, P., Matheson, J., Balaraju, L., Wickens, C. M., Foll, B. L., Rueda, S., & Ciano, P. D. (2026) · Journal of Cannabis Research · doi:10.1186/s42238-026-00444-6 · Cited by 2
Goodhines, P. A., Rathod, K., Schwarz, A. A., LaRowe, L. R., & Wedel, A. V. (2024) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2024.2308803 · Cited by 2
Should cannabis self-cultivation be part of a public health‒oriented legalization policy framework?
Fischer, B., & Robinson, T. (2024) · Canadian Journal of Public Health · doi:10.17269/s41997-024-00914-5 · Cited by 2
Wright-Brown, T., Blackwood, M., Cooper, T., Schwartz, E., Newell, W. J., Bishop, L. D., Najafizada, M., & Donnan, J. R. (2024) · Contemporary Drug Problems · doi:10.1177/00914509241271654 · Cited by 2
Oliveras, C., Cortez, P., Nuno, L., Colom, J., Kögel, C. C., Pascual, F., Fernández‐Artamendi, S., Gual, A., Balcells‐Oliveró, M., & López‐Pelayo, H. (2024) · European Addiction Research · doi:10.1159/000540541 · Cited by 2
Downey, M. K., Coles, A. R. L., & Harris, N. (2025) · Drugs Education Prevention and Policy · doi:10.1080/09687637.2025.2487452 · Cited by 2
Haddad, R., Fallu, J., Huỳnh, C., Gervais, M.-J., & Dagenais, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-96001-x · Cited by 2
Cannabinoids - Recent Perspectives and Applications in Human Health
JAMES, S. P. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100996 · Cited by 2
Kilmer, J. R., Hultgren, B. A., Delawalla, M. L. M., Gilson, M. S., Rhew, I. C., Fairlie, A. M., Martinez, G., & Guttmannova, K. (2024) · Current Addiction Reports · doi:10.1007/s40429-024-00579-7 · Cited by 2
Lake, S., & Cooper, Z. D. (2022) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20220675 · Cited by 2
Benefits and risks of cannabinoids
Freeman, T. P., & Hall, W. (2023) · BMJ · doi:10.1136/bmj.p2113 · Cited by 2
Pavlenko, T. A., & Mozghova, V. A. (2021) · Wiadomości Lekarskie · doi:10.36740/wlek202111233 · Cited by 1
Legalisation and Liberalisation of Cannabis: The Benefits and Drawbacks of the Global Trend
Fasesan, O. (2022) · Annals of Health Research (The Journal of the Medical and Dental Consultants Association of Nigeria OOUTH Sagamu Nigeria) · doi:10.30442/ahr.0803-01-168 · Cited by 1
Cannabis-Legalisierung in Deutschland
Fischer, B. (2023) · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · doi:10.1024/0939-5911/a000804 · Cited by 1
Harm reduction for perinatal cannabis use: protocol for a scoping review of clinical practices
Albanese, A. M., Littlewood, A., Creamer, A., Rogers, B. G., & Elwy, A. R. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-090453 · Cited by 1
Pain Intensity and Hazardous Cannabis Use: The Moderating Role of Pain-related Anxiety
Carlin, V. E., LaRowe, L. R., & Ditre, J. W. (2025) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2025.2511756 · Cited by 1
Phillips, K. T., Pedula, K. L., Tsuzaki, K., Erickson, C., Lai, J., Simiola, V., Wong, S., Pokhrel, P., & Satre, D. D. (2025) · Cannabis · doi:10.26828/cannabis/2025/000303 · Cited by 1
Kucera, A., & Hammond, D. (2025) · BMJ Public Health · doi:10.1136/bmjph-2024-001589 · Cited by 1
Cannabis Use Among Adolescents and Young Adults with Cancer: A Scoping Review
Schubel, L., McCready, D. M., LoParco, C. R., Arem, H. E., & Berg, C. J. (2025) · Journal of Cancer Education · doi:10.1007/s13187-025-02693-0 · Cited by 1
Rumpf, H., John, U., Seitz, H. K., Rehbein, F., Scherbaum, N., Havemann‐Reinecke, U., & Hayer, T. (2025) · Der Nervenarzt · doi:10.1007/s00115-025-01893-9 · Cited by 1
Rahal, D., & Waldron, K. A. (2025) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2025.2571148 · Cited by 1
Factors associated with lower-risk cannabis use in adults in their mid-thirties
Dubé, G., O’Loughlin, J. L., Fallu, J., Huỳnh, C., & Sylvestre, M. (2025) · Journal of Cannabis Research · doi:10.1186/s42238-025-00374-9 · Cited by 1
Bushnell, G., Olfson, M., Calello, D. P., Lloyd, K., Zhu, Y., & Samples, H. (2025) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2025.12.002 · Cited by 1
Challenges in establishing a link between THC exposure and cannabis use disorder
Manthey, J., Schranz, A., & Wardell, J. D. (2026) · Addiction · doi:10.1111/add.70364 · Cited by 1
Levy, S. M., Meghani, S. H., Worster, B. K., KILANOWSKI, C. K., Smith, D., Case, A. A., & Ashare, R. L. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-10523-2 · Cited by 1
Cannabis Use and Clinical Outcomes in First Episode Psychosis: Results From a 2‐Year Follow‐Up Study
Domenicano, I., Onofrio, A., Donatis, D. D., Malservigi, S., Vincenzo, G. D., Murri, M. B., Grassi, L. G., & Ferrara, M. (2026) · Early Intervention in Psychiatry · doi:10.1111/eip.70179 · Cited by 1
Fischer, B., Hall, W., Jutras‐Aswad, D., Foll, B. L., & Myran, D. T. (2026) · The Canadian Journal of Psychiatry · doi:10.1177/07067437261454772 · Cited by 1
Goodwin, I., Oliver, D., Chesney, E., Gaillard, A., Wang, S., koo, A. W., Petrilli, K., Skumlien, M., Dakhili, A. H., Wigroth, S., et al. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106795 · Cited by 1
Ortiz-Paredes, D., Knight, R., London-Nadeau, K., Goyette, M., Sylvestre, M., Flores-Aranda, J., Cotton, J.-C., & Ferlatte, O. (2026) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2026.105366 · Cited by 1
Sociodemographic Trends in Daily, Weekly and Less Than Weekly Cannabis Use in Australia
Leung, J., Chan, G., Zhang, R., Hall, W., & McClure‐Thomas, C. (2026) · Drug and Alcohol Review · doi:10.1111/dar.70207 · Cited by 1
Chester, L. A., Sharafi, H., Mahroug, A., Ziegler, D., Hébert, F.-O., & Jutras‐Aswad, D. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106910 · Cited by 1
Delile, J. (2022) · Psychotropes · doi:10.3917/psyt.281.0135 · Cited by 1
Cannabis harm reduction: perspectives of women who use and allied social and health-care providers
Janes, J., Baker, S. C. L., Bankovic, T., Abundo, J., Smith, A., & Ellenbogen, S. (2024) · Drugs Education Prevention and Policy · doi:10.1080/09687637.2024.2346655 · Cited by 1
Parvaresh, L., Mills, L., Gholami, J., Jansen, L., Jamshidi, N., Baker, K., Tremonti, C., Tracy, M., Dunlop, A. J., & Lintzeris, N. (2025) · Drug and Alcohol Review · doi:10.1111/dar.14074 · Cited by 1
Cannabis use patterns and comparison trends in Canada
Fischer, B., Jutras‐Aswad, D., Foll, B. L., & Myran, D. T. (2025) · Addiction · doi:10.1111/add.70146 · Cited by 1
Battista, K., Haddad, S. H. S., Leatherdale, S. T., & Bélanger, R. E. (2025) · Addictive Behaviors · doi:10.1016/j.addbeh.2025.108445 · Cited by 1
Hyatt, A. S. (2025) · Clinical Therapeutics · doi:10.1016/j.clinthera.2025.11.009 · Cited by 1
Sharma, B., Ghosh, A., Pillai, R. R., & Basu, D. (2022) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2022.2143458 · Cited by 1
Harm Reduction und Cannabis: Was ändert sich durch die Legalisierung?
Manthey, J. (2023) · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · doi:10.1024/0939-5911/a000798 · Cited by 1
Ishrat, S., Levey, D. F., Gelernter, J. E., Ebmeier, K. P., & Topiwala, A. (2023) · medRxiv · doi:10.1101/2023.08.12.23294013 · Cited by 1
Estimating thresholds for risk of cannabis use disorder using standard THC unitsPreprint
Lees, R., Lawn, W., Petrilli, K., Trinci, K., Borissova, A., Ofori, S., Mokrysz, C., Curran, H. V., Hines, L. A., & Freeman, T. P. (2025) · medRxiv · doi:10.1101/2025.05.21.25328059 · Cited by 1
Huỳnh, C., L’Espérance, N., Khadraoui, L., Jutras‐Aswad, D., Fleury, M., Kisely, S. R., LESAGE, A. D., & Massamba, V. K. (2025) · doi:10.64490/fxdb1984 · Cited by 1
Recommended Academic Reading (RAR).
(2022) · PubMed Central
Pediatric Brain on Cannabinoids: Adverse Effects of Cannabinoid Products in Children and Adolescents
Chase, P. B. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105983
Havemann‐Reinecke, U., Manthey, J., Verthein, U., Patzak, J., Thomasius, R., Tsamitros, N., & Gutwinksi, S. (2022) · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · doi:10.1024/0939-5911/a000792
Introduction to Cannabis for Medical Use
Valani, R. (2022) · Springer eBooks · doi:10.1007/978-3-031-12722-9_1
Die ‘Richtlinien für die Risiko-Reduzierung beim Cannabiskonsum (RRRCK)’: EMPFEHLUNGEN
Fischer, B., Robinson, T., Bullen, C., Curran, V. H., Jutras‐Aswad, D., Medina‐Mora, M. E., Pacula, R. L., Rehm, J. T., Room, R., van den Brink, W., et al. (2023) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2023.103995
Fischer, B., Robinson, T., Bullen, C., Curran, V. H., Jutras‐Aswad, D., Medina‐Mora, M. E., Pacula, R. L., Rehm, J. T., Room, R., van den Brink, W., et al. (2023) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2023.103996
Fischer, B., Robinson, T., Bullen, C., Curran, V. H., Jutras‐Aswad, D., Medina‐Mora, M. E., Pacula, R. L., Rehm, J. T., Room, R., van den Brink, W., et al. (2023) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2023.103994
Substance misuse and athletic performance
Kilmer, J. R., Gilson, M. S., & Graupensperger, S. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99992-2.00009-8
Gray, B. A., Bolts, O. L., Fitzke, R. E., Douglass, M. A., Pedersen, E. R., & Prince, M. A. (2023) · Substance Use & Misuse · doi:10.1080/10826084.2023.2267112
Brief Interventions for Cannabis Using Adolescents
Winters, K. C., Waldron, H. B., Hops, H., Ozechowski, T. J., & Montano, A. (2023) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2023.03.010
Cannabis Vape Product Sales in California Following CDC's Initial Advisory About Lung Injuries
Timberlake, D. S., Bruckner, T. A., Pechmann, C., Soroosh, A. J., Simard, B. J., Padon, A. A., & Silver, L. D. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0077
Réduction des risques et des dommages et approche intégrative
Delile, J. (2023) · Elsevier eBooks · doi:10.1016/b978-2-294-77934-3.00049-4
Sulastiana, S. (2024) · Cogent Social Sciences · doi:10.1080/23311886.2023.2289602
Watling, C. Z., Hammond, D. G., Turner, S., Nickel, N. C., Woodgate, R. L., & Balneaves, L. G. (2024) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-024-01246-8
Pierce, S. K., Reynolds, K. A., Sommer, J. L., El-Gabalawy, R. M., Pietrzak, R. H., Sumner, J. A., & Mota, N. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.06.028
Hall, W., & Fischer, B. (2024) · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · doi:10.1024/0939-5911/a000881
Pretorius, E. (2024) · Queensland University of Technology · doi:10.5204/thesis.eprints.251668
Rowe, E. C., Donnan, J. R., Drakes, D. H., & Bishop, L. D. (2024) · Journal of Adolescent Research · doi:10.1177/07435584241280274
Clarifying the Risks of Consuming Edible Cannabis—Reply
Incze, M. A., & Zhang, G. Y. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2024.5017
Crabtree, M. A., Stanley, L. R., Prince, M. A., & Swaim, R. C. (2024) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2024.104617
Reducing medical cannabis use risk among Veterans: A descriptive study
Harris-Lane, L. M., Sheehy, M. R., Loveless, C. A., Rash, J. A., Storey, D. P., Tippin, G. K., Parihar, V., & Harris, N. (2025) · Harm Reduction Journal · doi:10.1186/s12954-024-01149-w · Cited by 1
Côté, J., Chicoine, G., Auger, P., Vinette, B., Rouleau, G., Maheu‐Cadotte, M., Pagé, M. G., Lapierre, J., Lal, S., Genest, C., et al. (2026) · JMIR mhealth and uhealth · doi:10.2196/71957
Post-reform cannabis use and major depressive episode: A naturalistic investigation
Mumu, S. H., Folorunso, T. N., Badu, J. P., Hassan, N. F., & Reena, I. (2025) · Journal of Contemporary Studies in Epidemiology and Public Health · doi:10.29333/jconseph/16127
Goge, S., Singh, K., & Naidoo, K. (2025) · Student s Journal of Health Research Africa · doi:10.51168/sjhrafrica.v6i3.1564
Mapping the Landscape: A Scoping Review of Evaluated Substance Use Harm Reduction Programs for Youth
Rowe, E. C., Downey, M. K., Harris, N., Kinzel, E., Donnan, J. R., & Bishop, L. D. (2025) · Journal of Drug Education · doi:10.1177/00472379251335744
From relief to risks: a comprehensive review of medical cannabis
Lokhande, N., Mokal, A., Deshmukh, N. N., Borkar, A., & Patil, S. (2025) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20251740
Fischer, B., Robinson, T., & Albrecht, H. (2025) · Journal of Criminological Research Policy and Practice · doi:10.1108/jcrpp-06-2024-0042
Perception of Marijuana Usage Among Youths in Ilishan Community, Ogun StatePreprint
Eleagu, J. C., & Eleagu, J. C. (2025) · Research Square · doi:10.21203/rs.3.rs-6680696/v1
Wright-Brown, T., Williams, R. A., Blackwood, M., Najafizada, M., Cooper, T., Schwartz, E., Newell, W. J., Bishop, L. D., & Donnan, J. R. (2025) · Contemporary Drug Problems · doi:10.1177/00914509251352403
Minister, C., Hendershot, C. S., Keough, M. T., & Wardell, J. D. (2025) · Cannabis · doi:10.26828/cannabis/2025/000312 · Cited by 1
Cannabis-Legalisierung in Kanada: Kriminologisch relevante Daten und Entwicklungen
Fischer, B., Robinson, T., & Albrecht, H. (2025) · Monatsschrift für Kriminologie und Strafrechtsreform · doi:10.1515/mks-2025-0008
Canábis como conexão entre sustentabilidade e saúde: explorando seu potencial no Modelo One Health
Barcellos-Silva, I. G. C., Farias, C. D. R., Cardoso, B. D. C. C. C., Padilha, M. C., & da Veiga, V. F. (2025) · Revista Fitos · doi:10.32712/2446-4775.2025.1855
Borchardt, B., Klosterhalfen, S., & Kotz, D. (2025) · Journal of Cannabis Research · doi:10.1186/s42238-025-00329-0
Vogel, E. A., Romm, K. F., McMaughan, D., Zvolensky, M. J., Garey, L., & Businelle, M. S. (2025) · Cannabis · doi:10.26828/cannabis/2025/000305
Haddad, R., Fallu, J., Huỳnh, C., D’Arcy, L., Yuan, S., & Dagenais, C. (2025) · Health Research Policy and Systems · doi:10.1186/s12961-025-01411-y · Cited by 1
Fekih‐Romdhane, F., Alhuwailah, A., Shuwiekh, H. A. M., Stambouli, M., Hakiri, A., Cheour, M., Loch, A. A., & Hallit, S. (2024) · Figshare · doi:10.6084/m9.figshare.25656061
Additional file 1 of Emerging adult perceptions of higher-risk cannabis consumption behaviours
McMahon, I. D., Harris-Lane, L. M., Donnan, J. R., Bishop, L. D., & Harris, N. (2023) · Figshare · doi:10.6084/m9.figshare.24104422
Buschner, M., Heckel, N., Engeli, E. J. E., Havelka, E. M., Haas, M., Wick, J., Schneider, S., Duerler, P., Nordt, C., & Herdener, M. (2025) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-025-01614-y
Metadata
- Authors
- Fischer, B., Robinson, T., Bullen, C., Curran, V., Jutras-Aswad, D., Medina-Mora, M. E., Pacula, R. L., Rehm, J., Room, R., Brink, W. V. D., & Hall, W.
- Affiliations
- University of Auckland (NZ)
- Simon Fraser University (CA)
- National Institute for Health and Care Research (GB)
- University of Southern California (US)
- Centre for Addiction and Mental Health (CA)
- Stockholm University (SE)
- Amsterdam University Medical Centers (NL)
- The University of Queensland (AU)
- Corresponding author
- Fischer, Benedikt
- ORCID
- Venue
- International Journal of Drug Policy
- Publisher
- Elsevier BV
- Published
- 2022-01
- Volume
- 99
- Pages
- 103381
- ISSN
- 0955-3959 (ISSN-L)
- OpenAlex
- W3196591394
- Cited by
- 236
- References
- 335
- Citations by year
- 2026: 50 · 2025: 65 · 2024: 41 · 2023: 38 · 2022: 38
- FWCI
- 3.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- International Journal of Drug Policy (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by-nc-nd)
- La Trobe University
- Funders
- Health Canada
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- cannabis use, non-medical cannabis, modifiable risk factors, high-potency cannabis, THC, cannabis smoking, pregnant women, older adults, comorbidities, public health recommendations, expert consensus
- MeSH terms
- Adolescent, Aged, Cannabis, Female, Humans, Pregnancy, Public Health, Risk Factors, Exercise
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review